Back to 
STATE STREET CORP
STATE STREET CORP
PTGX11 quarters
Position history for STATE STREET CORP's holdings in PROTAGONIST THERAPEUTICS INC
STATE STREET CORP holds 3.3M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $407.2M as of 2026-Q2. The position was increased (+6.6% shares). PTGX represents 0.0% of STATE STREET CORP's portfolio.
Current Value
$407.2M
Current Shares
3.3M
Total Value Change
+$344.6M
Total Shares Change
+591,625
Quarter-by-Quarter History
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.